|[March 18, 2014]
Research and Markets: Orthobiologics Market Report 2013-2019: Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/sj346m/orthobiologics)
has announced the addition of the "Orthobiologics
Market Report 2013-2019: Allografts, Viscosupplements, DBM, BMP, Stem
Cell and Others" report to their offering.
The global orthobiologics market was valued at USD 3,754.6 million in
2012 and is expected to grow at a CAGR of 5.9% from 2013 to 2019 to
reach at an estimated value of USD 5,519.9 million in 2019.
This research report on orthobiologics provides detailed analysis of the
global market and helps in understanding the driving forces responsible
for the growth of this market. The report discusses the market of
orthobiologics on the basis of different orthobiologic products and
applications. The product segment comprises allografts, demineralized
bone matrix (DBM), bone morphogenetic proteins (BMPs),
viscosupplementation, synthetic bone graft substitutes, stem cell based
products and machined bone. The application segment is classified into
spinal fusion, trauma and reconstructive surgeries.
Orthobiology is a branch of science that develops bone and tissue
replacement materials for skeletal andtissue healing. Orthobiologics
has been gaining popularity since it provides accelerated healing,
faster recovery and reduction in number of hospital visits. A rise in
the incidence of arthritis and geriatric population has triggered the
growth of this market.
Moreover, an increase in the obesity rate coupled with rise in demand
for minimally invasive procedures has created a considerable demand for
bone graft substitutes. In addition, technological advancements, growing
patient awareness, rising incidences of road accidents and rising
participation in sports related activities has considerably augmented
the growth of this market.
Market size estimates and forecasts for the period 2011 to 2019 have
been provided for each of the segments, in terms of USD million, using
2012 as the base year. The CAGR (%) of each market segment for the
forecast period 2013 to 2019 has been provided along with market size
Scope of the Report
- Machined Bones
- Demineralized Bone Matrix (DBM)
- Bone Morphogenetic Proteins (BMPs)
- Stem Cell Therapy
- Synthetic Bone Substitutes
- Spinal Fusion
- Reconstructive Surgery
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Global Orthobiologics Market, by Product
Chapter 5 Global Orthobiologics Market, by Application
Chapter 6 Global Orthobiologics Market, by Geography
Chapter 7 Global Orthobiologics Market Share Analysis
Chapter 8 Recommendations
Chapter 9 Company Profiles
Alphatec Spine, Inc.
Bacterin International, Inc.
DePuy Synthes, Inc. (A Johnson & Johnson Company)
Globus Medical, Inc.
Integra LifeSciences Corporation
Orthofix Holdings, Inc.
Regeneration Technologies, Inc.
Wright Medical Technology, Inc.
Zimmer Holdings, Inc.
For more information visit http://www.researchandmarkets.com/research/sj346m/orthobiologics
[ Back To TMCnet.com's Homepage ]